IHM
CTMX icon

Iguana Healthcare Management’s CytomX Therapeutics CTMX Stock Holding History

Iguana Healthcare Management’s Portfolio CTMX Stock Details CTMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		$1.85M Sell
65,000
-10,000
-13% -$285K 1.22% 35
2017
Q4 		$1.58M Buy
75,000
+5,000
+7% +$104K 1.03% 42
2017
Q3 		$1.27M Buy
70,000
+10,000
+17% +$156K 0.69% 47
2017
Q2 		$930K Sell
60,000
-15,000
-20% -$226K 0.53% 50
2017
Q1 		$1.29M Buy
+75,000
New +$987K 0.64% 48

Other funds holding CTMX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TG
TRV GP Boston, Massachusetts $18.9M AUM 541.67% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Iguana Healthcare Management's CTMX Position: Q1 2018 in Review

Iguana Healthcare Management reduced its CytomX Therapeutics (CTMX) stake by 13% in Q1 2018, selling an estimated $285K and leaving 65,000 shares worth $1.85M. The position accounts for 1.22% of the portfolio, ranked #35.

Iguana Healthcare Management first reported a position in CTMX in Q1 2017 and has held it in 5 quarters since. 141 funds tracked by Wall St. Rank hold CTMX as of Q1 2018.

  • Iguana Healthcare Management held 65,000 shares of CytomX Therapeutics worth $1.85M as of Q1 2018.
  • Iguana Healthcare Management sold 10,000 CytomX Therapeutics shares in Q1 2018, an estimated $285K.
  • CytomX Therapeutics made up 1.22% of Iguana Healthcare Management's portfolio in Q1 2018, its #35 holding.
  • Iguana Healthcare Management first reported a position in CytomX Therapeutics in Q1 2017 and has held it in 5 quarters since.
  • 141 funds tracked by Wall St. Rank held CytomX Therapeutics as of Q1 2018.

Based on Iguana Healthcare Management's 13F filing for Q1 2018, filed 15 May 2018.